These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 9244566)

  • 1. [A modeling analysis of possible generic substitutions in an inpatient facility].
    Urbánek K; Vareková P
    Ceska Slov Farm; 1997 Apr; 46(2):74-7. PubMed ID: 9244566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Generic drug prescribing: pilot study on the impact of the new drug pricing system on costs and potential savings].
    Wasserfallen JB; Shimia S; Biollaz J; Pannatier A
    Rev Med Suisse; 2006 Mar; 2(59):865-6, 868-71. PubMed ID: 16646370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inventory management to reduce costs: a case study.
    Wilson S
    Hosp Pharm; 1995 Sep; 30(9):759-61, 765-6. PubMed ID: 10151280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The potential impact of implementing a system of generic substitution on the community drug schemes in Ireland.
    Tilson L; Bennett K; Barry M
    Eur J Health Econ; 2005 Sep; 6(3):267-73. PubMed ID: 15977036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drugmakers fight for good name. Stakes high, challenges many for providers who seek generic products.
    Becker C
    Mod Healthc; 2001 Aug; 31(35):28-33, 1. PubMed ID: 11550428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of managerial intervention on drug utilization pattern at King Chulalongkorn Memorial Hospital.
    Limpanasithikul W; Wangsaturaka D; Nantawan P; Itthipanichapong C; Thamaree S; Wittayalertpanya S; Ketcharoen A; Taworn N; Kemsri W; Kusolsomboon T; Tangphao O
    J Med Assoc Thai; 2002 Jun; 85 Suppl 1():S336-43. PubMed ID: 12188432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reducing outpatient costs of nonsteroidal antiinflammatory drugs at a Department of Veterans Affairs teaching hospital.
    Drexler PG; Lambdin CS
    J Pharm Technol; 1993; 9(1):10-3. PubMed ID: 10123760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Generic substitution, replacement and substitution of drugs: contemporary extent].
    Macesková B; Blechová R; Blahozová E; Hadámková K
    Ceska Slov Farm; 2011 Apr; 60(2):73-8. PubMed ID: 21650009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Strategies for pharmaceutical research and development. II. Generic drugs].
    Kuchar M
    Ceska Slov Farm; 1996 Jul; 45(4):171-6. PubMed ID: 8925240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extensions of intellectual property rights and delayed adoption of generic drugs: effects on medicaid spending.
    Kesselheim AS; Fischer MA; Avorn J
    Health Aff (Millwood); 2006; 25(6):1637-47. PubMed ID: 17102189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential savings from increased use of generic drugs in the elderly: what the experience of Medicaid and other insurance programs means for a Medicare drug benefit.
    Fischer MA; Avorn J
    Pharmacoepidemiol Drug Saf; 2004 Apr; 13(4):207-14. PubMed ID: 15255087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of mail-service and retail community pharmacy claims in 5 prescription benefit plans.
    Clark BE; Siracuse MV; Garis RI
    Res Social Adm Pharm; 2009 Jun; 5(2):133-42. PubMed ID: 19524861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In that case: a pharmaceutical company that makes generic versions of commonly used drugs has produced a generic of a proprietary drug widely prescribed in a particular service. Response.
    Grice S
    N Z Bioeth J; 2003 Oct; 4(3):22-4. PubMed ID: 15597479
    [No Abstract]   [Full Text] [Related]  

  • 14. Generic drug utilisation on the General Medical Services (GMS) scheme in 2001.
    Tilson L; McGowan B; Ryan M; Barry M
    Ir Med J; 2003 Jun; 96(6):176-9. PubMed ID: 12926759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Society already achieves economic benefits from generic substitution but fails to do the same for therapeutic substitution.
    Gumbs PD; Verschuren WM; Souverein PC; Mantel-Teeuwisse AK; de Wit GA; de Boer A; Klungel OH
    Br J Clin Pharmacol; 2007 Nov; 64(5):680-5. PubMed ID: 17875197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attitudes of Slovene general practitioners towards generic drug prescribing and comparison with international studies.
    Kersnik J; Peklar J
    J Clin Pharm Ther; 2006 Dec; 31(6):577-83. PubMed ID: 17176362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In that case: a pharmaceutical company that makes generic versions of commonly used drugs has produced a generic of a proprietary drug widely prescribed in a particular service. Response.
    Adams J
    N Z Bioeth J; 2003 Oct; 4(3):22-3. PubMed ID: 15597478
    [No Abstract]   [Full Text] [Related]  

  • 18. In that case: a pharmaceutical company that makes generic versions of commonly used drugs has produced a generic of a proprietary drug widely prescribed in a particular service. Response.
    Menkes DB; Woodall AA
    N Z Bioeth J; 2003 Oct; 4(3):22, 24-5. PubMed ID: 15597480
    [No Abstract]   [Full Text] [Related]  

  • 19. In that case: a pharmaceutical company that makes generic versions of commonly used drugs has produced a generic of a proprietary drug widely prescribed in a particular service. Response.
    Woolner D
    N Z Bioeth J; 2003 Oct; 4(3):22, 25-6. PubMed ID: 15597481
    [No Abstract]   [Full Text] [Related]  

  • 20. [Generic drugs change in hospitals].
    Johansen R; Fosnes GS; Holm H; Løken G; Englund K; Jørgensborg K; Skovly Ø; Dybendal T; Strøm I
    Tidsskr Nor Laegeforen; 2007 May; 127(9):1232-3. PubMed ID: 17479146
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.